The HIV-1 vpr Protein Acts as a Negative Regulator of Apoptosis in a Human Lymphoblastoid T Cell Line: Possible Implications for the Pathogenesis of AIDS

作者: L. Conti , G. Rainaldi , P. Matarrese , B. Varano , R. Rivabene

DOI: 10.1084/JEM.187.3.403

关键词:

摘要: Although apoptosis is considered one of the major mechanisms CD4+ T cell depletion in HIV-infected patients, virus-infected cells somehow appear to be protected from apoptosis, which generally occurs bystander cells. Vpr an auxiliary HIV-1 protein, which, unlike other regulatory gene products, present at high copy number virus particles. We established stable transfectants Jurkat constitutively expressing low levels vpr. These clones exhibited cycle characteristics similar those control-transfected Treatment control with apoptotic stimuli (i.e., cycloheximide/tumor necrosis factor α (TNF-α), anti-Fas antibody, or serum starvation) resulted a massive death by apoptosis. In contrast, all vpr-expressing showed impressive protection independently inducer. Notably, vpr antisense phosphorothioate oligodeoxynucleotides render as susceptible induced cycloheximide and TNF-α clones. Moreover, constitutive expression upregulation bcl-2, oncogene endowed antiapoptotic activities, downmodulation bax, proapoptotic bcl-2 family. Altogether, these results suggest that endogenous protein can interfere physiological turnover lymphocytes early stages infection, thus facilitating HIV persistence and, subsequently, viral spread. This might explain why mostly uninfected AIDS patients.

参考文章(61)
J B Jowett, V Planelles, B Poon, N P Shah, M L Chen, I S Chen, The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle Journal of Virology. ,vol. 69, pp. 6304- 6313 ,(1995) , 10.1128/JVI.69.10.6304-6313.1995
G. Zauli, D. Milani, M. Mazzoni, D. Gibellini, P. Borgatti, S. Capitani, M. La Placa, Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Research. ,vol. 53, pp. 4481- 4485 ,(1993)
Thomas W. McCloskey, Melanie Ott, Savita Pahwa, Eric Verdin, Morris O. Paul, Narendra Chirmule, Narendra Chirmule, Narendra Chirmule, Shabbir A. Khan, Saul Teichberg, Eugene Tribble, Dual role of HIV Tat in regulation of apoptosis in T cells. Journal of Immunology. ,vol. 158, pp. 1014- 1019 ,(1997)
H Zhu, Y Shen, T Shenk, Human cytomegalovirus IE1 and IE2 proteins block apoptosis. Journal of Virology. ,vol. 69, pp. 7960- 7970 ,(1995) , 10.1128/JVI.69.12.7960-7970.1995
R A Subbramanian, E A Cohen, Molecular biology of the human immunodeficiency virus accessory proteins. Journal of Virology. ,vol. 68, pp. 6831- 6835 ,(1994) , 10.1128/JVI.68.11.6831-6835.1994
C Lavallée, X J Yao, A Ladha, H Göttlinger, W A Haseltine, E A Cohen, Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles. Journal of Virology. ,vol. 68, pp. 1926- 1934 ,(1994) , 10.1128/JVI.68.3.1926-1934.1994
J He, S Choe, R Walker, P Di Marzio, D O Morgan, N R Landau, Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. Journal of Virology. ,vol. 69, pp. 6705- 6711 ,(1995) , 10.1128/JVI.69.11.6705-6711.1995